The use of phenylbutazone in the horse

Journal of Veterinary Pharmacology and Therapeutics

Volumn 35, Issue 1, 2012, Pages 1-12

  Soma, L R ^a   Uboh, C E ^b   Maylin, G M ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEST CHESTER UNIVERSITY   (United States)

^c State University of New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ARACHIDONIC ACID DERIVATIVE; BUTORPHANOL; CARPROFEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; ETODOLAC; FIROCOXIB; FLUNIXIN MEGLUMINE; FLURBIPROFEN; HYALURONIC ACID; IBUPROFEN; INDOMETACIN; KETOPROFEN; MEPIVACAINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PHENYLBUTAZONE; PLACEBO; PROCAINE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SERUM ALBUMIN; SUXIBUZONE;

ALBUMIN BLOOD LEVEL; ANALGESIA; ANALGESIC ACTIVITY; ANESTHESIA; ANIMAL LAMENESS; ARTHROSCOPIC SURGERY; BLOOD BRAIN BARRIER; BLOOD DYSCRASIA; CAPILLARY PERMEABILITY; CARPAL BONE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; ENDURANCE TRAINING; ENZYME ACTIVITY; ENZYME INHIBITION; FOOT PAIN; HEALING; HEMODYNAMICS; HUMAN; HYDRATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTESTINE BIOPSY; INTESTINE ULCER; JOINT CAVITY; JOINT SWELLING; KIDNEY NECROSIS; LARGE INTESTINE PERFORATION; LIPOPHILICITY; LOADING DRUG DOSE; LONG TERM CARE; LOW DRUG DOSE; MORPHOMETRICS; MUSCLE INJURY; NEUTROPENIA; NOCICEPTION; NONHUMAN; OSTEOARTHRITIS; PAIN ASSESSMENT; PAIN THRESHOLD; PEROPERATIVE CARE; PH; PHARMACOKINETICS; PHYSICAL CHEMISTRY; PHYSIOTHERAPY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BINDING; PROTEOGLYCAN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANGE OF MOTION; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; REVIEW; RISK REDUCTION; SINGLE DRUG DOSE; SPORTS MEDICINE; SPRAIN; SYNOVIAL FLUID; SYNOVITIS; SYNOVIUM; TENDINITIS; TENDON; TREADMILL EXERCISE; TREATMENT DURATION; ULCERATIVE COLITIS; VETERINARY MEDICINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HORSE DISEASES; HORSES; LEGISLATION, DRUG; PHENYLBUTAZONE; SPORTS;

EQUIDAE;

EID: 84855476219     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2011.01299.x     Document Type: Review

References (124)

1. Angst, M.S., Clark, J.D., Carvalho, B., Tingle, M., Schmelz, M. and Yeomans, D.C. (2008a) Cytokine profile in human skin in response to experimental inflammation, noxious stimulation, and administration of a COX-inhibitor: a microdialysis study. Pain, 139, 15-27.
2. Angst, M.S., Tingle, M., Schmelz, M., Carvalho, B. and Yeomans, D.C., (2008b) Human in-vivo bioassay for the tissue-specific measurement of nociceptive and inflammatory mediators. Journal of Visualized Experiments, 22.
3. Armstrong, S. and Lees, P. (1999) Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants. American Journal Veteterinary Research, 60, 98-104.
4. Armstrong, S., Tricklebank, P., Lake, A., Frean, S. and Lees, P. (1999) Pharmacokinetics of carprofen enantiomers in equine plasma and synovial fluid - a comparison with ketoprofen. Journal of Veterinary Pharmacology and Therapeutics, 22, 196-201.
5. Authie, E.C., Garcia, P., Popot, M.A., Toutain, P.L. and Doucet, M. (2010) Effect of an endurance-like exercise on the disposition and detection time of phenylbutazone and dexamethasone in the horse: application to medication control. Equine Veterinary Journal, 42, 240-247.
6. Bannwarth, B., Netter, P., Pourel, J., Royer, R.J. and Gaucher, A. (1989) Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid. Biomedicine and Pharmacotherapy, 43, 121-126.
7. Barragry, T.B. (1973) Phenylbutazone in equine practice: a review. Irish Veterinary Journal, 27, 143-147.
8. Beluche, L.A., Bertone, A.L., Anderson, D.E. and Rohde, C. (2001) Effects of oral administration of phenylbutazone to horses on in vitro articular cartilage metabolism. American Journal Veteterinary Research, 62, 1916-1921.
9. Beretta, C., Garavaglia, G. and Cavalli, M. (2005) COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis. Pharmacological Research, 52, 302-306.
10. Birch, N.C., Sly, C., Brooks, S. and Powles, D.P. (1993) Anti-inflammatory drug therapy after arthroscopy of the knee. A prospective, randomised, controlled trial of diclofenac or physiotherapy. Journal of Bone and Joint Surgery - British Volume, 75, 650-652.
11. Bird, H.A., Leatham, P.A., Lowe, J.R., Downie, W.W., Fowler, P.D. and Wright, V. (1983) A phenylbutazone dose-finding study in rheumatoid arthritis. European Journal of Clinical Pharmacology, 24, 773-776.
12. Birks, E.K., Gory, S.N., Li, C. and Jones, J.H. (1991) Effect of exercise on plasma prostaglandins and thromboxane B2. In Equine Exercise Physiology. Eds. Persson, S.G.B., Lindholm, A. and Jeffcot, L.B., pp. 374-379, ICEEP Publications, Davis, CA.
13. Brideau, C., Van Staden, C. and Chan, C.C. (2001) In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats. American Journal of Veterinary Research, 62, 1755-1760.
14. Brooks, P.M., Walker, J.J. and Dick, W.C. (1975) Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis. British Journal of Clinical Pharmacology, 2, 437-442.
15. Cannon, J. (1973) The use of phenylbutazone on the race track. Proceedings of the Nineteenth Annual Convention of the American Association of Equine Practitioners, pp. 347-349.AAEP, Lexington.
16. Chay, S., Woods, W.E., Nugent, T.E., Weckman, T., Houston, T., Sprinkle, F., Blake, J.W., Tobin, T., Soma, L.R., Yocum, J. and Smith, J.D. (1984) Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses. Journal of Veterinary Pharmacology and Therapeutics, 7, 265-276.
17. Collins, L.G. and Tyler, D.E. (1984) Phenylbutazone toxicosis in the horse: a clinical study. Journal of the American Veterinary Medical Association, 184, 699-703.
18. Dawson, J., Lees, P. and Sedgwick, A.D. (1987) Actions of non-steroidal anti-inflammatory drugs on equine leucocyte movement in vitro. Journal of Veterinary Pharmacology and Therapeutics, 10, 150-159.
19. Day, R.O., Graham, G.G., Williams, K.M., Champion, G.D. and de Jager, J. (1987) Clinical pharmacology of non-steroidal anti-inflammatory drugs. Pharmacology and Therapeutics, 33, 383-433.
20. Demers, L.M., Harrison, T.S., Halbert, D.R. and Santen, R.J. (1981) Effect of prolonged exercise on plasma prostaglandin levels. Prostaglandins and Medicine, 6, 413-418.
21. Dirikolu, L., Woods, W.E., Boyles, J., Lehner, A.F., Harkins, J.D., Fisher, M., Schaeffer, D.J. and Tobin, T. (2009) Nonsteroidal anti-inflammatory agents and musculoskeletal injuries in Thoroughbred racehorses in Kentucky. Journal of Veterinary Pharmacology and Therapeutics, 32, 271-279.
22. Dokmeci, D. and Dokmeci, D. (2004) Ibuprofen and Alzheimer's disease. Folia Medica (Plovdiv), 46, 5-10.
23. Doucet, M.Y., Bertone, A.L., Hendrickson, D., Hughes, F., Macallister, C., McClure, S., Reinemeyer, C., Rossier, Y., Sifferman, R., Vrins, A.A., White, G., Kunkle, B., Alva, R., Romano, D. and Hanson, P.D. (2008) Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis. Journal of the American Veterinary Medical Association, 232, 91-97.
24. Dunn, P.S. (1972) A clinician's views on the use and misuse of phenylbutazone. Equine Veterinary Journal, 4, 63-65.
25. Erkert, R.S., MacAllister, C.G., Payton, M.E. and Clarke, C.R. (2005) Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome. American Journal of Veterinary Research, 66, 284-288.
26. Famaey, J.P. (1985) Correlation plasma levels, NSAID and therapeutic response. Clinical Rheumatology, 4, 124-132.
27. Farr, M., Hawkins, C.F., Kendall, M.J. and Willis, J.V. (1982) Some observations and speculations on the factors influencing the concentration of phenylbutazone in synovial fluid. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 20, 589-594.
28. Fischer, H.B., Simanski, C.J., Sharp, C., Bonnet, F., Camu, F., Neugebauer, E.A., Rawal, N., Joshi, G.P., Schug, S.A. and Kehlet, H. (2008) A procedure-specific systematic review and consensus recommendations for postoperative analgesia following total knee arthroplasty. Anaesthesia, 63, 1105-1123.
29. Foreman, J.H., Barange, A., Lawrence, L.M. and Hungerford, L.L. (2008) Effects of single-dose intravenous phenylbutazone on experimentally induced, reversible lameness in the horse. Journal of Veterinary Pharmacology and Therapeutics, 31, 39-44.
30. Fournier, P.E., Leal, S. and Ziltener, J.-L. (2008) Sports injuries and NSAID. Revue Medicale Suisse, 4, 1702-1705.
31. Fowler, P.D., Shadforth, M.F., Crook, P.R. and John, V.A. (1983) Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis. European Journal of Clinical Pharmacology, 25, 389-394.
32. Frean, S.P., Abraham, L.A. and Lees, P. (1999) In vitro stimulation of equine articular cartilage proteoglycan synthesis by hyaluronan and carprofen. Research in Veterinary Science, 67, 183-190.
33. Frisbie, D.D., McIlwraith, C.W., Kawcak, C.E., Werpy, N.M. and Pearce, G.L. (2009) Evaluation of topically administered diclofenac liposomal cream for treatment of horses with experimentally induced osteoarthritis. American Journal of Veteterinary Research, 70, 210-215.
34. Furst, D.E. (1985) Synovial fluid kinetics of non-steroidal anti-inflammatory drugs. Agents and Actions - Supplements, 17, 65-78.
35. Gabel, A.A., Tobin, T., Ray, R.S. and Maylin, G.A. (1977) Phenylbutazone in Horses: a Review. Journal of Equine Medicine and Surgery, 1, 221-225.
36. Gaucher, A., Netter, P., Faure, G., Schoeller, J.P. and Gerardin, A. (1983) Diffusion of oxyphenbutazone into synovial fluid, synovial tissue, joint cartilage and cerebrospinal fluid. European Journal of Clinical Pharmacology, 25, 107-112.
37. Goodrich, L.R. and Nixon, A.J. (2006) Medical treatment of osteoarthritis in the horse - a review. Veterinary Journal, 171, 51-69.
38. Gowen, R.R. and Lengel, J.G. (1993) Regulatary aspects of drug use in performance horses. Veterinary Clinics of North Amercia: Equine Practice, 9, 449-460.
39. Graf, P., Glatt, M. and Brune, K. (1975) Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue. Experientia, 31, 951-953.
40. Grennan, D.M., Aarons, L. and Salisbury, R. (1985) Problems with demonstrating NSAID concentration-response relationships. Agents and Actions-Supplements, 17, 163-168.
41. Gunson, D.E. (1983) Renal papillary necrosis in horses. Journal of the American Veterinary Medical Association, 182, 263-266.
42. Harvey, S.K. (1983) Statement by Dr. S.K. Harvey. American Association of Equine Practitioners, Newsletter, 2, 25-26.
43. Higgins, A.J. and Lees, P. (1984) Arachidonic acid metabolites in carrageenin-induced equine inflammatory exudate. Journal of Veterinary Pharmacology and Therapeutics, 7, 65-72.
44. Higgins, A.J., Lees, P. and Taylor, J.B. (1984) Influence of phenylbutazone on eicosanoid levels in equine acute inflammatory exudate. Cornell Veterinarian, 74, 198-207.
45. Higgins, A.J., Lees, P. and Sedgwick, A.D. (1987a) Development of equine models of inflammation. Veterinary Record, 120, 517-522.
46. Higgins, A.J., Lees, P., Sharma, S.C. and Taylor, J.B. (1987b) Measurement of flunixin in equine inflammatory exudate and plasma by high performance liquid chromatography. Equine Veterinary Journal, 19, 303-306.
47. Higgs, G.A. (1980) Arachidonic acid metabolism, pain and hyperalgesia: the mode of action of non-steroid mild analgesics. British Journal of Clinical Pharmacology, 10 (Suppl. 2), 233S-235S.
48. Hinchcliff, K.W., McKeever, K.H. and Muir, W.W. 3rd (1994) Effect of phenylbutazone on the haemodynamic, acid-base and eicosanoid responses of horses to sustained submaximal exertion. Research in Veterinary Science, 56, 352-362.
49. Houdeshell, J.W. and Hennessey, P.W. (1977) A new nonsteroidal, anti inflammatory analgesic for horses. Journal of Equine Medicine and Surgery, 1, 57-63.
50. Houston, T., Chay, S., Woods, W.E., Combs, G., Kamerling, S., Blake, J.W., Edmundson, A.G., Vessiney, R. and Tobin, T. (1985) Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH. Journal of Veterinary Pharmacology and Therapeutics, 8, 136-149.
51. Hu, H.H., MacAllister, C.G., Payton, M.E. and Erkert, R.S. (2005) Evaluation of the analgesic effects of phenylbutazone administered at a high or low dosage in horses with chronic lameness. Journal of the American Veterinary Medical Association, 226, 414-417.
52. Huang, Y.M., Wang, C.M., Wang, C.T., Lin, W.P., Horng, L.C. and Jiang, C.-C. (2008) Perioperative celecoxib administration for pain management after total knee arthroplasty - a randomized, controlled study. BMC Musculoskeletal Disorders, 9, 77.
53. Jeffcott, L.B. and Colles, C.M. (1977) Phenylbutazone and the horse - a review. Equine Veterinary Journal, 9, 105-110.
54. Johnson, C.B., Taylor, P.M., Young, S.S. and Brearley, J.C. (1993) Postoperative analgesia using phenylbutazone, flunixin or carprofen in horses. Veterinary Record, 133, 336-338.
55. Kamerling, S., DeQuick, D.J., Crisman, M., Weckman, T., Nugent, T.E. and Tobin, T. (1983) Phenlybutazone: lack of effect on normal cutaneous pain perception in the horse. Proceedings, 5th International Conference of Drugs in Race Horses, pp. 85-87, Toronto, Canada.
56. Kamerling, S.G., Dequick, D.J., Weckman, T.J., Sprinkle, F.P. and Tobin, T. (1984) Differential effects of phenylbutazone and local anesthetics on nociception in the equine. European Journal of Pharmacology, 107, 35-41.
57. Kamerling, S.G., Weckman, T.J., DeQuick, D.J. and Tobin, T. (1985) A method for studying cutaneous pain perception and analgesia in horses. Journal of Pharmacological Methods, 13, 267-274.
58. Karcher, L.F., Dill, S.G., Anderson, W.I. and King, J.M. (1990) Right dorsal colitis. Journal of Veterinary Internal Medicine, 4, 247-253.
59. Keegan, K.G., Messer, N.T., Reed, S.K., Wilson, D.A. and Kramer, J. (2008) Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses. American Journal of Veterinary Research, 69, 167-173.
60. Krzyzanski, W. and Jusko, W.J. (2001) Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition. Journal of Pharmacokineics Pharmacodynmics, 28, 57-78.
61. Layzell, M. and Layzell, M. (2008) Current interventions and approaches to postoperative pain management. British Journal of Nursing, 17, 414-419.
62. Lees, P. and Higgins, A.J. (1984) Flunixin inhibits prostaglandin E2 production in equine inflammation. Research in Veterinary Science, 37, 347-349.
63. Lees, P. and Higgins, A.J. (1985) Clinical pharmacology and therapeutic uses of non-steroidal anti-inflammatory drugs in the horse. Equine Veterinary Journal, 17, 83-96.
64. Lees, P. and Higgins, A.J. (1986) Effects of a phenylbutazone paste in ponies: model of acute nonimmune inflammation. American Journal of Veterinary Research, 47, 2359-2363.
65. Lees, P., Taylor, J.B., Higgins, A.J. and Sharma, S.C. (1986) Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse. Journal of Veterinary Pharmacology and Therapeutics, 9, 204-212.
66. Lees, P., Ewins, C.P., Taylor, J.B. and Sedgwick, A.D. (1987a) Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin. British Veterinary Journal, 143, 462-476.
67. Lees, P., Higgins, A.J., Sedgwick, A.D. and May, S.A. (1987b) Applications of equine models of acute inflammation. The Ciba-Geigy Prize for Research in Animal Health. Veterinary Record, 120, 522-529.
68. Lees, P., Cunningham, F.M. and Elliott, J. (2004a) Principles of pharmacodynamics and their applications in veterinary pharmacology. Journal of Veterinary Pharmacology and Therapeutics, 27, 397-414.
69. Lees, P., Giraudel, J., Landoni, M.F. and Toutain, P.L. (2004b) PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology. Journal of Veterinary Pharmacology and Therapeutics, 27, 491-502.
70. Lees, P., Landoni, M.F., Giraudel, J. and Toutain, P.L. (2004c) Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest. Journal of Veterinary Pharmacology and Therapeutics, 27, 479-490.
71. MacAllister, C.G., Morgan, S.J., Borne, A.T. and Pollet, R.A. (1993) Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. Journal of the American Veterinary Medical Association, 202, 71-77.
72. Manohar, M., Goetz, T.E., Griffin, R. and Sullivan, E. (1996) Pulmonary vascular pressures of strenuously exercising thoroughbreds after administration of phenylbutazone. American Journal of Veterinary Research, 57, 1354-1358.
73. Mather, L.E. (1992) Do the pharmacodynamics of the nonsteroidal anti-inflammatory drugs suggest a role in the management of postoperative pain? Drugs, 44 (Suppl. 5), 1-12.
74. McConnico, R.S., Morgan, T.W., Williams, C.C., Hubert, J.D. and Moore, R.M. (2008) Pathophysiologic effects of phenylbutazone on the right dorsal colon in horses. American Journal of Veterinary Research, 69, 1496-1505.
75. McCormack, K. and Brune, K. (1991) Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs, 41, 533-547.
76. Mehallo, C.J., Drezner, J.A. and Bytomski, J.R. (2006) Practical management: nonsteroidal antiinflammatory drug (NSAID) use in athletic injuries. Clinical Journal of Sport Medicine, 16, 170-174.
77. Meschter, C.L., Gilbert, M., Krook, L., Maylin, G. and Corradino, R. (1990a) The effects of phenylbutazone on the intestinal mucosa of the horse: a morphological, ultrastructural and biochemical study. Equine Veterinary Journal, 22, 255-263.
78. Meschter, C.L., Gilbert, M., Krook, L., Maylin, G. and Corradino, R. (1990b) The effects of phenylbutazone on the morphology and prostaglandin concentrations of the pyloric mucosa of the equine stomach. Veterinary Pathology, 27, 244-253.
79. Mills, P.C., Ng, J.C. and Auer, D.E. (1996) The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses. Journal of Veterinary Pharmacology and Therapeutics, 19, 475-481.
80. Mitten, L.A., Hinchcliff, K.W., Pate, J.L., Kohn, C.W. and McKeever, K.H. (1995) Effect of exercise intensity on plasma prostaglandin concentrations in horses. American Journal of Veterinary Research, 56, 122-126.
81. Mitten, L.A., Hinchcliff, K.W. and Pate, J.L. (1996) Phenylbutazone increases right atrial pressure and heart rate of running horses. Journal of Applied Physiology, 81, 312-317.
82. Moncada, S., Ferreira, S.H. and Vane, J.R. (1974) The blockade of the local generation of prostaglandins explains the analgesic action of aspirin. Polish Journal of Pharmacology and Pharmacy, 26, 77.
83. Morton, A.J., Campbell, N.B., Gayle, J.M., Redding, W.R. and Blikslager, A.T. (2005) Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis. Research in Veterinary Science, 78, 189-192.
84. Moses, V.S., Hardy, J., Bertone, A.L. and Weisbrode, S.E. (2001) Effects of anti-inflammatory drugs on lipopolysaccharide-challenged and -unchallenged equine synovial explants. American Journal of Veterinary Research, 62, 54-60.
85. Netter, P., Bannwarth, B., Monot, C., Royer, R.J. and Gaucher, A. (1983) Passage of nonsteroidal anti-inflammatory agents across the synovial membrane. Presse Medicale, 12, 2049-2052.
86. Netter, P., Lapicque, F., Bannwarth, B., Tamisier, J.N., Thomas, P. and Royer, R.J. (1985) Diffusion of intramuscular ketoprofen into the cerebrospinal fluid. European Journal of Clinical Pharmacology, 29, 319-321.
87. Netter, P., Bannwarth, B. and Royer-Morrot, M.J. (1989) Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid. Clinical Pharmacokinetics, 17, 145-162.
88. Obel, N. (1948) Studies on the Histopathology of Acute Laminitis. Almqvist and Wisells Boktryckteri AK, Uppsala, Sweden.
89. O'Connor, J.P., Lysz, T., O'Connor, J.P. and Lysz, T. (2008) Celecoxib, NSAIDs and the skeleton. Drugs of Today, 44, 693-709.
90. Ogilvie-Harris, D.J., Bauer, M. and Corey, P. (1985) Prostaglandin inhibition and the rate of recovery after arthroscopic meniscectomy. A randomised double-blind prospective study. Journal of Bone and Joint Surgery - British Volume, 67, 567-571.
91. Owens, J.G., Kamerling, S.G., Stanton, S.R. and Keowen, M.L. (1995) Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse. Equine Veterinary Journal, 27, 296-300.
92. Parepally, J.M., Mandula, H., Smith, Q.R., Parepally, J.M.R., Mandula, H. and Smith, Q.R. (2006) Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin. Pharmaceutical Research, 23, 873-881.
93. Puchalski, T.A., Krzyzanski, W., Blum, R.A. and Jusko, W.J. (2001) Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model. Journal of Clinical Pharmacology, 41, 251-258.
94. Raekallio, M., Taylor, P.M. and Bennett, R.C. (1997) Preliminary investigations of pain and analgesia assessment in horses administered phenylbutazone or placebo after arthroscopic surgery. Veterinary Surgery, 26, 150-155.
95. Rasmussen, S., Thomsen, S., Madsen, S.N., Rasmussen, P.J. and Simonsen, O.H. (1993) The clinical effect of naproxen sodium after arthroscopy of the knee: a randomized, double-blind, prospective study. Arthroscopy, 9, 375-380.
96. Read, W.K. (1983) Renal medullary crest necrosis associated with phenylbutazone therapy in horses. Veterinary Pathology, 20, 662-669.
97. Reed, S.K., Messer, N.T., Tessman, R.K. and Keegan, K.G. (2006) Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses. American Journal of Veterinary Research, 67, 398-402.
98. Reilly, F.K. (2000) Questions duration of treatment with phenylbutazone. American Journal of Veterinary Research, 61, 728.
99. Reuben, S.S. and Reuben, S.S. (2007) Update on the role of nonsteroidal anti-inflammatory drugs and coxibs in the management of acute pain. Current Opinion in Anaesthesiology, 20, 440-450.
100. Rohde, C., Anderson, D.E., Bertone, A.L. and Weisbrode, S.E. (2000) Effects of phenylbutazone on bone activity and formation in horses. American Journal of Veterinary Research, 61, 537-543.
101. Ross, M.W. (2003) Movement. In Diagnosis and Management of Lameness in the Horse. Eds: Ross, M.W. and Dyson, S.J., pp 62. Saunders, Philadelphia.
102. Ross, M.W., Martin, B.B. and Donawick, W.J. (1985) Cecal perforation in the horse. Journal of the American Veterinary Medical Association, 187, 249-253.
103. Sabate, D., Homedes, J., Salichs, M., Sust, M. and Monreal, L. (2009) Multicentre, controlled, randomised and blinded field study comparing efficacy of suxibuzone and phenylbutazone in lame horses. Equine Veterinary Journal, 41, 700-705.
104. Sanford, J. (1974) Doping of horses. British Journal of Sports Medicine, 8, 176-180.
105. Sanford, J. (1983) Effects of drugs on performance of the horse. In Pharmacological Basis of Large Animal Medicine. Eds. Bogan, J.A., Lees, P. and Yoxall, A.T., pp. 495-510, Blackwell Scientific Publications, Boston, MA.
106. Schoonover, M.J., Jann, H.W. and Blaik, M.A. (2005) Quantitative comparison of three commonly used treatments for navicular syndrome in horses. American Journal of Veterinary Research, 66, 1247-1251.
107. Schug, S.A., Manopas, A., Schug, S.A. and Manopas, A. (2007) Update on the role of non-opioids for postoperative pain treatment. Best Practice and Research Clinical Anaesthesiology, 21, 15-30.
108. Semrad, S.D., Sams, R.A., Harris, O.N. and Ashcraft, S.M. (1993) Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares. American Journal of Veterinary Research, 54, 1901-1905.
109. Simkin, P.A. (1988) Concentration-effect relationships of NSAID. Journal of Rheumatology - Supplement, 17, 40-43.
110. Soma, L.R., Gallis, D.E., Davis, W.L., Cochran, T.A. and Woodward, C.B. (1983) Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration. American Journal of Veterinary Research, 44, 2104-2109.
111. Soma, L.R., Sams, R., Duer, W., Tobin, T., Woodward, C. and McDonald, J. (1985) Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing thoroughbreds 24 hours after treatment with various dosage regimens. American Journal of Veterinary Research, 46, 932-938.
112. Soma, L.R., Uboh, C.E., Rudy, J. and Fegely, J. (1992) Plasma concentrations of flunixin in the horse: its relationship to thromboxane B2 production. Journal of Veterinary Pharmacology and Therapeutics, 15, 292-300.
113. Soma, L.R., Uboh, C.E., Rudy, J.A. and Perkowski, S.Z. (1995) Plasma and synovial fluid kinetics, disposition, and urinary excretion of naproxen in horses. American Journal of Veterinary Research, 56, 1075-1080.
114. Taylor, J.B., Verrall, J.H., Chandler, N., Jones, R.D. and Parker, J. (1983a) Clinical efficacy of a revised dosage schedule of phenylbutazone in horses. Veterinary Record, 113, 183-184.
115. Taylor, J.B., Walland, A., Lees, P., Gerring, E.L., Maitho, T.E. and Millar, J.D. (1983b) Biochemical and haematological effects of a revised dosage schedule of phenylbutazone in horses. Veterinary Record, 112, 599-602.
116. Tobin, T. (1981) Phenylbutazone and its brothers: non-steroidal anti-inflamatory drugs. In Drugs and the Performance Horse, pp. 87. Charles C. Thomas, Springfield, IL.
117. Tobin, T., Chay, S., Kamerling, S., Woods, W.E., Weckman, T.J., Blake, J.W. and Lees, P. (1986) Phenylbutazone in the horse: a review. Journal of Veterinary Pharmacology and Therapeutics, 9, 1-25.
118. Toutain, P.L. and Lees, P. (2004) Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27 (6), 467-477.
119. Toutain, P.L., Autefage, A., Legrand, C. and Alvinerie, M. (1994) Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling. Journal of Veterinary Pharmacology and Therapeutics, 17, 459-469.
120. Vane, J.R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature - New Biology, 231, 232-235.
121. Vane, J.R. and Botting, R. (1987) Inflammation and the mechanism of action of anti-inflamatory drugs. FASEB Journal, 1, 89-96.
122. Woods, W.E., Chay, S., Houston, T., Blake, J.W. and Tobin, T. (1985a) Effects of phenylbutazone and oxyphenbutazone on basic drug detection in high performance thin layer chromatographic systems. Journal of Veterinary Pharmacology and Therapeutics, 8, 181-189.
123. Woods, W.E., Chay, S., Houston, T., Blake, J.W. and Tobin, T. (1985b) Efficacy of testing for illegal medication in horses. Journal of the American Veterinary Medical Association, 187, 927-930.
124. Woods, W.E., Weckman, T., Blake, J.W. and Tobin, T. (1986) Effects of phenylbutazone and oxyphenbutazone on acidic drug detection in high performance thin layer chromatographic systems. Journal of Pharmacological Methods, 16, 297-313.